Dalteparin sodium

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

1789 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Thrombosis	D013927	—	—	13	36	60	49	100	245
Thromboembolism	D013923	—	—	9	37	76	37	68	216
Venous thromboembolism	D054556	EFO_0004286	I74	9	37	75	32	73	215
Venous thrombosis	D020246	—	I82.40	8	28	48	41	63	179
Covid-19	D000086382	—	U07.1	6	28	35	14	39	108
Pulmonary embolism	D011655	EFO_0003827	I26	10	10	33	26	34	108
Embolism	D004617	—	—	8	8	24	18	25	78
Myocardial infarction	D009203	EFO_0000612	I21	—	4	17	23	25	68
Hemorrhage	D006470	MP_0001914	R58	1	7	13	14	26	59
Infarction	D007238	EFO_0009463	—	—	4	9	17	25	54

Show 187 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	18	3	1	—	5	25
Septic shock	D012772	—	A48.3	2	4	2	—	14	22
Cardiovascular diseases	D002318	EFO_0000319	I98	—	2	5	—	14	21
Multiple myeloma	D009101	—	C90.0	3	4	3	—	6	15
Pain	D010146	EFO_0003843	R52	—	1	1	—	11	12
Replacement arthroplasty knee	D019645	—	—	—	5	3	—	1	9
Plasma cell neoplasms	D054219	—	—	3	2	2	—	3	9
Newborn respiratory distress syndrome	D012127	—	P22	2	4	2	—	4	9
Lymphoma	D008223	—	C85.9	2	3	1	—	3	8
Bone fractures	D050723	EFO_0003931	T14.8	—	1	3	—	4	8

Show 105 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Cholangiocarcinoma	D018281	—	C22.1	1	5	—	—	1	7
Coronary stenosis	D023921	EFO_1000882	—	—	1	—	—	4	5
Congenital heart defects	D006330	—	Q24.9	1	1	—	—	3	5
Carotid artery diseases	D002340	EFO_0003781	—	—	1	—	—	3	4
Myeloid leukemia	D007951	—	C92	3	1	—	—	—	4
Ovarian neoplasms	D010051	EFO_0003893	C56	—	3	—	—	1	4
Renal cell carcinoma	D002292	EFO_0000376	—	2	1	—	—	2	4
Systemic inflammatory response syndrome	D018746	EFO_1001478	R65.10	—	1	—	—	3	4
Large b-cell lymphoma diffuse	D016403	—	C83.3	1	2	—	—	1	3
B-cell lymphoma	D016393	—	—	2	2	—	—	—	3

Show 64 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Blood platelet disorders	D001791	—	—	1	—	—	—	3	4
Blood pressure	D001794	EFO_0004325	—	2	—	—	—	1	3
Intracranial hypertension	D019586	EFO_1000992	—	1	—	—	—	1	2
Non-hodgkin lymphoma	D008228	—	C85.9	1	—	—	—	1	2
Hodgkin disease	D006689	—	C81	1	—	—	—	1	2
Congenital abnormalities	D000013	EFO_0003915	Q89.9	1	—	—	—	1	2
Systemic lupus erythematosus	D008180	EFO_0002690	M32	1	—	—	—	1	2
Neuroblastoma	D009447	EFO_0000621	—	1	—	—	—	1	2
Sensorineural hearing loss	D006319	—	H90.5	1	—	—	—	1	2
Nasopharyngeal carcinoma	D000077274	—	—	1	—	—	—	—	1

Show 23 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Postoperative complications	D011183	—	—	—	—	—	—	6	6
Carotid stenosis	D016893	—	—	—	—	—	—	6	6
Chest pain	D002637	—	R07.9	—	—	—	—	5	5
Pathologic constriction	D003251	—	—	—	—	—	—	5	5
Non-alcoholic fatty liver disease	D065626	EFO_0003095	K75.81	—	—	—	—	4	4
Tuberculosis	D014376	EFO_0000774	A15-A19	—	—	—	—	4	4
Platelet activation	D015539	—	—	—	—	—	—	4	4
Post-acute covid-19 syndrome	D000094024	—	—	—	—	—	—	4	4
Drug-related side effects and adverse reactions	D064420	—	T88.7	—	—	—	—	3	3
Cytokine release syndrome	D000080424	—	D89.83	—	—	—	—	3	3